Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PGNY US Equity

Progyny, Inc.Health Care · Services-Misc Health & Allied Services, NEC · CIK 1551306 · FY ends Dec 31
$25.71
+0.38 (+1.50%)
USD · as of 2026-08-18 · marketstack
10 registered studies · 0 active

Studies where PGNY is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

1 interventional · 9 observational

Held by 18 tracked-famous managers (CITADEL ADVISORS LLC, BAILLIE GIFFORD & CO, JANE STREET GROUP, LLC, AQR CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, +13 more) · FINRA short interest 4.6 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 9 sells · government filings 180d: 0 congress / 1 executive

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
US Eeva™ Pregnancy Investigational Clinical Study (US EPIC)NCT01671657observationalRate of implantationUnknown statusInfertility100Jun 20162015-10-20
Eeva™ Pregnancy Pilot Study (PPS)NCT02218255Clinical PregnancyRandomized · Open-label · TreatmentNot applicableUnknown statusDevice: Eeva™ resultsInfertility240Mar 20162015-10-20
Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)NCT02141685observationalEeva time-lapse parameters and aCGH testing resultsUnknown statusInfertility50Feb 20162015-07-13
Eeva System Imaging StudyNCT02301637observationalAdverse events and device malfunctions will be reported and summarized from the point of Eeva imaging through study exit.Unknown statusDevice: Eeva™ TestInfertility500Dec 20152015-07-13
Eeva™ Pregnancy Investigational Clinical Study: A Postmarket Follow-Up StudyNCT01671644observationalRate of clinical pregnancyCompletedInfertility104Jun 2015actual2015-10-20
Registry Study of Traditional Morphology Grading Combined With Eeva in IVF TreatmentNCT01816802observationalClinical Pregnancy RateUnknown statusDevice: In-vitro fertilization using EevaInfertility1,200Jun 20152015-03-26
Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening ResultsNCT01635049observationalEeva time-lapse parameters and CCSCompletedInfertility110Dec 2014actual2015-01-14
Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical SettingNCT01617993observationalUser questionnaire of Eeva System usability and reports of device malfunctions.CompletedInfertility31Feb 2013actual2014-01-13
Eeva 12-well Dish StudyNCT01635036observationalTo validate and develop the Eeva Software.CompletedDevice: In-vitro fertilization using EevaInfertility17Aug 2012actual2014-01-13
Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst StageNCT01369446observationalEeva System correctly predicts on day 2 those embryos that will reach blastocyst stage at day 5.CompletedDevice: Eeva System StudyInfertility160Apr 2012actual2012-07-24

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19